Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients

Autor:	Hardev Pandha, Rachel E. Sanborn, M.R. Zibelman, R. Jennens, Charles M. Rudin, Timothy D. Clay, Gavin M. Wright, Christy Ralph, Steven J. O'Day, Emmett V. Schmidt, Sumati Gupta, Mark Grose, Brendan D. Curti, Wallace Akerley, Darren R. Shafren, David Campbell, Jonathan E. Rosenberg, A.G. Hill, David E. Gerber, D. Day
Rok vydání:	2018
Předmět:	0301 basic medicine Bladder cancer business.industry Coxsackievirus A21 Hematology Pembrolizumab medicine.disease Oncolytic virus 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Oncology 030220 oncology & carcinogenesis Cancer research medicine business
Zdroj:	Annals of Oncology. 29:viii732
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy424.050
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3959000b8294ab25ea99b71b1bf512de https://doi.org/10.1093/annonc/mdy424.050 Zobrazit plný text záznamu